Can phthalates, PFAS, and mycotoxins impair insulin sensitivity and glucose metabolism?

Clinical and metabolic evidence

Human cohort and experimental studies demonstrate that environmental exposure to phthalates, PFAS, and mycotoxins alters systemic glucose regulation:

• Phthalates: Higher urinary concentrations of phthalate metabolites (such as DEHP and its active metabolites) are associated with elevated fasting insulin and increased homeostatic model assessment of insulin resistance (HOMA-IR).
• PFAS: Elevated serum levels of PFAS correlate with impaired fasting glucose, elevated fasting insulin, and increased HOMA-IR.
• Mycotoxins: Exposure to toxins like ochratoxin A (OTA) and aflatoxin B1 (AFB1) impairs insulin-stimulated glucose uptake and shifts cellular metabolism away from efficient mitochondrial oxidative phosphorylation toward less efficient glycolysis.

Mechanistic explanations

These three distinct classes of environmental toxicants converge on several cellular pathways to drive insulin resistance and glucose dysregulation:

• Endocrine disruption: Phthalates act as endocrine-disrupting chemicals that impair insulin sensitivity and beta-cell survival. PFAS function as direct ligands for nuclear receptors, specifically activating PPAR-alpha and PPAR-gamma to alter lipid handling and metabolic homeostasis. Mycotoxins systematically disrupt endocrine-regulated lipid and glucose pathways.
• Mitochondrial dysfunction: In multiple cell models, PFAS exposure reduces basal, maximal, and ATP-linked oxygen consumption rates (OCR) and inhibits electron transport chain complexes, or induces UCP-mediated uncoupling. Mycotoxins (OTA and AFB1) decrease mitochondrial membrane potential, cause structural damage, and impair ATP production. Phthalates likewise compromise mitochondrial membrane potential and ATP synthesis.
• Oxidative stress: Phthalates and PFAS elevate clinical biomarkers of oxidative stress and DNA damage (e.g., malondialdehyde and 8-OHdG) by driving excess reactive oxygen species (ROS) generation. Mycotoxins dramatically elevate ROS while depleting key antioxidant enzymes, such as superoxide dismutase (SOD) and glutathione peroxidase (GPx).
• Impaired insulin signaling: Excessive cellular ROS and mitochondrial dysfunction activate stress-sensitive kinases (specifically JNK and p38 MAPK). These kinases induce inhibitory serine phosphorylation of insulin receptor substrate-1 (IRS-1), which blocks downstream Akt signaling and prevents GLUT4 transporter translocation to the plasma membrane, halting glucose uptake.

Bottom line

• There is high-confidence evidence that phthalates, PFAS, and mycotoxins disrupt endocrine, mitochondrial, and oxidative stress pathways. These cellular perturbations collectively impair IRS-1/Akt signaling and GLUT4 translocation, leading to peripheral insulin resistance and compromised systemic glucose homeostasis.